Journal
/
Medicina
/
Neurodegeneration in an Animal Model of Chronic Amyloid-beta Oligomer Infusion Is Counteracted by Antibody Treatment Infused with Osmotic Pumps
JoVE Revista
Medicina
This content is Free Access.
JoVE Revista Medicina
Neurodegeneration in an Animal Model of Chronic Amyloid-beta Oligomer Infusion Is Counteracted by Antibody Treatment Infused with Osmotic Pumps

Neurodegeneration in an Animal Model of Chronic Amyloid-beta Oligomer Infusion Is Counteracted by Antibody Treatment Infused with Osmotic Pumps

9,031 Views

•

10:19 min

•

August 14, 2016

DOI:

10.3791/54215-v

DOI:
10.3791/54215-v

•

10:19 min
August 14, 2016

•

8 Views
, , ,
1Department of Pharmacology,Université de Montréal, 2Department of Neuroscience,Université de Montréal, 3Hôpital du Sacré-coeur de Montréal Research Center,Université de Montréal

Summary

Automatically generated

To study the effects of Aβo in vivo, we developed a model based on repeated hippocampal infusions of soluble Aβo coupled with continuous infusion of Aβo antibody (6E10) in the hippocampus using osmotic pumps to counteract the neurotoxic effect of Aβo.

Explore More Videos

Amyloid-beta OligomerNeurodegenerationAlzheimer’s DiseaseAnimal ModelAntibody TreatmentOsmotic PumpsCannula ImplantationStereotaxic FrameNeurotoxicityImmunotherapy

Read Article

Cite this Article

Sajadi, A., Provost, C., Pham, B., Brouillette, J. Neurodegeneration in an Animal Model of Chronic Amyloid-beta Oligomer Infusion Is Counteracted by Antibody Treatment Infused with Osmotic Pumps. J. Vis. Exp. (114), e54215, doi:10.3791/54215 (2016).

Download .ris file

Copy

Share Video

.

Copy